Lee, J. C.; Hung, J.-Y.; Kim, Y.-C.; Chang, G.-C.; Yoo, S.; Yang, S.-H.; Davis, K.; Nagar, S.; Taylor, A.; Lee, S.; Shih, J.-Y. Real-World Treatment Patterns in Patients With EGFR Mutation-Positive NSCLC Receiving a First-Line, First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in South Korea and Taiwan. apjcb 2021, 6, 123-132.